spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Lyrica 

 HSMN NewsFeed - 2 Feb 2022
Bexion Pharmaceuticals Announces Leadership Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2020
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2020
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 29 Jul 2019
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2013
Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2013
Royalty Pharma Announces Firm Offer to Acquire Elan
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2013
Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Nov 2012
Zogenix Appoints New Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Jun 2012
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 May 2012
Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2012
Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2011
Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (prebabalin) Capsules CV In Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2011
Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
Biopharmaceuticals
 HSMN NewsFeed - 12 Oct 2010
Pfizer to Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 May 2010
Adeona Completes a $17.5 Million Corporate Partnership With Meda AB for the Development and Commercialization of Flupirtine for Fibromyalgia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 May 2010
Meda Acquires Exclusive Rights to flupirtine for fibromyalgia, a Potential USD Billion Indication
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Sep 2009
Pfizer Concludes Previously Disclosed Settlement Agreement With U.S. Department Of Justice Regarding Past Promotional Practices
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2009
Lyrica Significantly Reduced Pain and Improved Other Symptoms of Post-Traumatic Peripheral Nerve Pain, New Data Show
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Feb 2009
Pfizer Discontinues Development of Two Phase 3 Compounds
Biopharmaceuticals
 HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2008
Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2008
Lyrica Reduced Pain of Fibromyalgia in Patients Regardless of Symptoms of Anxiety or Depression
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Mar 2008
Pfizer Presents New Opportunities for Global Growth
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2007
Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2007
Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2007
PTC Therapeutics Appoints Theresa Natalicchio as Senior Vice President of Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2007
Pfizer's Lyrica Receives FDA Approval for Fibromyalgia Based on Expedited Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 May 2007
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 22 Jan 2007
Pfizer Announces Priorities to Drive Improved Performance, Position Company for Future Success and Enhance Total Shareholder Return
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2006
Pfizer's Lyrica(R) Approved in Europe for Difficult-to-Treat Nerve Pain
Biopharmaceuticals Regulatory
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
Lyrica
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!